Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

274 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Exploratory studies on CA-15L, an anti-HIV active HIV-1 capsid fragment.
Tsuji K, Owusu KB, Kobayakawa T, Wang R, Fujino M, Kaneko M, Yamamoto N, Murakami T, Tamamura H. Tsuji K, et al. Among authors: tamamura h. Bioorg Med Chem. 2020 Jun 1;28(11):115488. doi: 10.1016/j.bmc.2020.115488. Epub 2020 Apr 8. Bioorg Med Chem. 2020. PMID: 32305183
A novel anti-HIV synthetic peptide, T-22 ([Tyr5,12,Lys7]-polyphemusin II).
Masuda M, Nakashima H, Ueda T, Naba H, Ikoma R, Otaka A, Terakawa Y, Tamamura H, Ibuka T, Murakami T, et al. Masuda M, et al. Among authors: tamamura h. Biochem Biophys Res Commun. 1992 Dec 15;189(2):845-50. doi: 10.1016/0006-291x(92)92280-b. Biochem Biophys Res Commun. 1992. PMID: 1472056
Structure-activity relationships of an anti-HIV peptide, T22.
Tamamura H, Murakami T, Masuda M, Otaka A, Takada W, Ibuka T, Nakashima H, Waki M, Matsumoto A, Yamamoto N, et al. Tamamura H, et al. Biochem Biophys Res Commun. 1994 Dec 30;205(3):1729-35. doi: 10.1006/bbrc.1994.2868. Biochem Biophys Res Commun. 1994. PMID: 7811258
Solution-phase synthesis of an anti-human immunodeficiency virus peptide, T22 ([Tyr5,12,Lys7]-polyphemusin II), and the modification of Trp by the p-methoxybenzyl group of Cys during trimethylsilyl trifluoromethanesulfonate deprotection.
Tamamura H, Otaka A, Takada W, Terakawa Y, Yoshizawa H, Masuda M, Ibuka T, Murakami T, Nakashima H, Waki M, et al. Tamamura H, et al. Chem Pharm Bull (Tokyo). 1995 Jan;43(1):12-8. doi: 10.1248/cpb.43.12. Chem Pharm Bull (Tokyo). 1995. PMID: 7895303
Interaction of an anti-HIV peptide, T22, with gp120 and CD4.
Tamamura H, Otaka A, Murakami T, Ishihara T, Ibuka T, Waki M, Matsumoto A, Yamamoto N, Fujii N. Tamamura H, et al. Biochem Biophys Res Commun. 1996 Feb 15;219(2):555-9. doi: 10.1006/bbrc.1996.0272. Biochem Biophys Res Commun. 1996. PMID: 8605026
An anti-HIV peptide, T22, forms a highly active complex with Zn(II).
Tamamura H, Otaka A, Murakami T, Ibuka T, Sakano K, Waki M, Matsumoto A, Yamamoto N, Fujii N. Tamamura H, et al. Biochem Biophys Res Commun. 1996 Dec 13;229(2):648-52. doi: 10.1006/bbrc.1996.1858. Biochem Biophys Res Commun. 1996. PMID: 8954952
274 results